Загрузка...
A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms
Myeloproliferative neoplasms are a varied group of disorders that can have prolonged chronic phases, but eventually accelerate and can transform into a secondary acute myeloid leukemia that is ultimately fatal. Triapine is a novel inhibitor of the M2 subunit of ribonucleotide reductase. Sequential i...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Ferrata Storti Foundation
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3971077/ https://ncbi.nlm.nih.gov/pubmed/24362550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.097246 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|